Siemens Healthineers AG

  • WKN: SHL100
  • ISIN: DE000SHL1006
  • Land: Deutschland

Nachricht vom 03.01.2019 | 16:19

Siemens Healthineers AG: Release of a capital market information

Siemens Healthineers AG / Disclosure pursuant to art. 5 para. 1 lit. b),
para. 3 of the Regulation (EU) no. 596/2014 Share buyback - Final Report

03.01.2019 / 16:19
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Disclosure pursuant to art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) no. 596/2014 Share buyback - Final Report, and 6th Interim Reporting Siemens Healthineers AG completes share buyback On 2 January 2019 a total number of 33,035 shares were bought back within the scope of the share buyback of Siemens Healthineers AG. Notice of commencement of this share buyback on 26 November 2018 for a time period until and including 25 January 2019 was made on 23 November 2018 by Siemens Healthineers AG pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014 (MAR) and Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052. Shares were bought back as follows:

Day of purchase           Aggregated volume of      Weighted average price
                          shares
01/02/2019                33,035                    36.9748


With these transactions, the share buyback was completed on 2 January 2019. The total number of treasury shares which were bought back within the scope of this share buyback in the time period from 26 November 2018 until and including 2 January 2019 amounts to 1,205,012 shares. This corresponds to 0.12% of the share capital. The purchase price paid at the stock exchange was on average EUR 37.3440 per share; the total consideration that was paid for the treasury shares amounts to EUR 44,999,989.28 (excluding incidental transaction charges). The purchase of the shares of Siemens Healthineers AG was carried out by an investment firm mandated by Siemens Healthineers AG; the shares were repurchased exclusively on the electronic trading platform of the Frankfurt Stock Exchange (Xetra). Detailed information on each transaction is published on the website of Siemens Healthineers AG (www.corporate.siemens-healthineers.com/investor- relations). Munich, 3 January 2019 Siemens Healthineers AG The Managing Board
03.01.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Language: English Company: Siemens Healthineers AG Henkestr. 127 91052 Erlangen Germany Internet: https://www.corporate.siemens-healthineers.com End of News DGAP News Service

Interview im Fokus

HanseYachts: „Der ideale Zeitpunkt für den Kauf“

Die Übernahme des Katamaran-Herstellers Privilège bringt die HanseYachts AG dem Umsatzziel von 200 Mio. Euro einen bedeutenden Schritt näher. „Der Katamaran-Markt ist das derzeit am stärksten wachsende Segment im Yacht-Geschäft. Privilège ist weltweit in Preis und Qualität die Nummer eins“, so CEO Dr. Jens Gerhardt. Zudem sei der Deal ein wichtiger Faktor, um die EBITDA-Marge auf 10 bis 12 % zu steigern. Im Financial.de-Interview spricht der Konzernlenker über die aktuellsten Trends im Yacht-Geschäft, die laufende Barkapitalerhöhung sowie die Weltpremieren in Cannes.

GBC-Fokusbox

Fonds Research 2019: S.E.A. Asian High Yield Bond bietet attraktive Investitionschance

Auch 2019 hat die GBC AG unter der Vielzahl an Publikumsfonds neun „Fonds Champions“ herausgefiltert. Darunter auch den S.E.A. Asian High Yield Bond (ISIN: LU1138637738), der eine gute Anlagechance anbietet mit einer Strategie, die kaum reproduzierbar ist. Insbesondere vor dem Hintergrund des anhaltenden Niedrigzinsniveaus sehen wir den Anleihefonds als äußerst attraktive Investitionschance, um nachhaltige und volatilitätsarme Renditen zu erzielen. Wir haben den S.E.A. Asian High Yield Bond mit 4 von 5 Falken eingestuft.

Aktueller Webcast

EQS Group AG

Conference Call zu den Halbjahreszahlen 2019

16. August 2019

Aktuelle Research-Studie

HELMA Eigenheimbau AG

Original-Research: HELMA Eigenheimbau AG (von GBC AG): Kaufen

22. August 2019